Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testing

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1044-1053

  Bissonnette, L ^a,b   Bergeron, M G ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Diagnosis of infectious diseases; Home testing; Point of care; Rapid diagnostics; Review; Technologies

Indexed keywords

CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA SEQUENCE; EARLY DIAGNOSIS; GENE AMPLIFICATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HOME DIAGNOSTIC TEST; HUMAN; IMMUNOASSAY; INFECTION; LAB ON A CHIP; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MICROORGANISM DETECTION; MICROSCOPY; MOLECULAR RECOGNITION; NANOBIOTECHNOLOGY; NONHUMAN; NUCLEIC ACID ANALYSIS; POINT OF CARE TESTING; PRIORITY JOURNAL; PROCESS TECHNOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; COMMUNICABLE DISEASES; HOSPITAL INFORMATION SYSTEM; MOLECULAR DIAGNOSIS; PROCEDURES; TRENDS;

COMMUNICABLE DISEASES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE SYSTEMS;

EID: 77955141712     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03282.x     Document Type: Review

References (102)

1. Millar BC, Xu J, Moore JE. Molecular diagnostics of medically important infections. Curr Issues Mol Biol 2007, 9:21-40.
2. Cohen ML. Changing patterns of infectious disease. Nature 2000, 406:762-767.
3. Mortality and morbidity of infectious diseases. http://www.globalhealth.org/infectious_diseases/mortality_morbidity, Available at: (last accessed 15 April 2010)
4. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999, 281:61-66.
5. Picard FJ, Bergeron MG. Rapid molecular theranostics in infectious diseases. Drug Discov Today 2002, 7:1092-1100.
6. Bissonnette L, Bergeron MG. The next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine. Expert Rev Mol Diagn 2006, 6:433-450.
7. Kumar A, Roberts D, Wood KE. Duration of hypotension before initiation of antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
8. Dellinger RP, Levy MM, Carlet JM. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
9. McGeer A, Green KA, Plevneshi A. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45:1568-1575.
10. Nissen MD, Sloots TP. Rapid diagnosis in pediatric infectious diseases: the past, the present, and the future. Pediatr Infect Dis 2002, 21:605-612.
11. Ehrmeyer SS, Laessig RH. Point-of-care testing, medical error, and patient safety: a 2007 assessment. Clin Chem Lab Med 2007, 45:766-773.
12. Jahn UR, Van Aken H. Near-patient testing-point-of-care or point of costs and convenience? Br J Anaesth 2003, 90:425-427.
13. Grodzinsky E, Wirehn A-B, Fremner E. Point-of-care testing has a limited effect on time to clinical decision in primary health care. Scand J Clin Lab Invest 2004, 64:547-552.
14. Meier FA, Jones BA. Point-of-care testing error-sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med 2005, 129:1262-1267.
15. Nichols JH. Point of care testing. Clin Lab Med 2007, 27:893-908.
16. Huckle D. Point-of-care diagnostics: an advancing sector with nontechnical issues. Expert Rev Mol Diagn 2008, 8:679-688.
17. Plebani M. Does POCT reduce the risk of error in laboratory testing? Clin Chim Acta 2009, 404:59-64.
18. Rajan A, Glorikian H. Point-of-care diagnostics: market trends and growth drivers. Expert Opin Med Diagn 2009, 3:1-4.
19. Trevino EA, Weissfeld AS. The case for point-of-care testing in infectious-disease diagnosis. Clin Microbiol Newsl 2007, 29:177-179.
20. Overturf GD. CLIA waived testing in infectious diseases. Pediatr Infect Dis J 2008, 27:1009-1012.
21. Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol 2006, 4:682-695.
22. Ryan A, Wilson S, Greenfield S. Range of self-tests available to buy in the United Kingdom: an Internet survey. J Public Health 2006, 28:370-374.
23. Campbell S. My point-of-care wish list. Point Care 2008, 7:95-97.
24. Charles PGP. Early diagnosis of lower respiratory tract infections (point-of-care tests). Curr Opin Pulm Med 2008, 14:176-182.
25. Murray CK, Gasser RA, Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev 2008, 21:97-110.
26. Campbell S, Fedoriw Y. HIV testing near the patient: changing the face of HIV testing. Clin Lab Med 2009, 29:491-501.
27. Chappel RJ, Wilson KM, Dax EM. Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing. Future Microbiol 2009, 4:963-982.
28. Madhivan P, Krupp K, Hardin J. Simple and inexpensive point-of-care tests improve diagnosis of vaginal infections in resource constrained settings. Trop Med Int Health 2009, 14:703-708.
29. Michel C-EC, Saison FG, Joshi H. Pitfalls of internet-accessible diagnostic tests: inadequate performance of a CE-marked Chlamydia test for home use. Sex Transm Infect 2009, 85:187-189.
30. Pearson J. Point-of-care-testing and clinical governance. Clin Chem Lab Med 2006, 44:765-767.
31. Nissinen A, Strandén P, Myllyus R. Point-of-care testing of group A streptococcal antigen: performance evaluated by external quality assessment. Eur J Clin Microbiol Infect Dis 2009, 28:17-20.
32. Schimke I. Quality and timeliness in medical laboratory testing. Anal Bioanal Chem 2009, 393:1499-1504.
33. Mabey D, Peeling RW, Ustianowski A, Perkins MD. Diagnostics for the developing world. Nat Rev Microbiol 2004, 2:231-240.
34. Urdea M, Penny LA, Olmsted SS. Requirements for high impact diagnostics in the developing world. Nature 2006, 444(suppl 1):73-79.
35. Peters RPH, van Agtmael MA, Danner SA. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004, 4:751-760.
36. Wongsrichanalai C, Barcus MJ, Muth S. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 2007, 77(suppl 6):119-127.
37. Perkins MD, Bell DR. Working without a blindfold: the critical role of diagnostics in malaria control. Malar J 2008, 7(suppl 1):S5.
38. Green C, Huggett JF, Talbot E. Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods. Lancet Infect Dis 2009, 9:505-511.
39. Hazelton PR, Gelderblom HR. Electron microscopy for rapid diagnosis of infectious agents in emergent situations. Emerg Infect Dis 2003, 9:294-303.
40. Dwarakanath S, Bruno JG, Shastry A. Quantum dot-antibody and aptamer conjugates shift fluorescence upon binding bacteria. Biochem Biophys Res Commun 2004, 325:739-743.
41. Shamah SM, Healy JM, Cload ST. Complex target SELEX. Acc Chem Res 2008, 41:130-138.
42. Ulrich H, Wrenger C. Disease-specific biomarker discovery by aptamers. Cytometry 2009, 75A:727-733.
43. Kammila S, Das D, Bhatnagar PK. A rapid point of care immunoswab assay for SARS-CoV detection. J Virol Methods 2008, 152:77-84.
44. Mayer G. The chemical biology of aptamers. Angew Chem Int Ed 2009, 48:2672-2689.
45. Platt M, Rowe W, Wedge DC. Aptamer evolution for array-based diagnostics. Anal Biochem 2009, 390:203-205.
46. Chan CP-y, Cheung Y-c, Renneberg R, Seydack M. New trends in immunoassays. Adv Biochem Eng/Biotechnol 2008, 109:123-154.
47. Blicharz TM, Siqueira WL, Helmerhorst EJ. Fiber-optic microsphere-based antibody array for the analysis of inflammatory cytokines in saliva. Anal Chem 2009, 81:2106-2114.
48. van Lieshout RML, van Domburg T, Saalmink M. Three-dimensional flow-through protein platform. Anal Chem 2009, 81:5165-5171.
49. Ohk SH, Koo OK, Sen T. Antibody-aptamer functionalized fibre-optic biosensor for specific detection of Listeria monocytogenes from food. J Appl Microbiol 2010, doi:
50. Weile J, Knabbe C. Current applications and future trends of molecular diagnostics in clinical bacteriology. Anal Bioanal Chem 2009, 394:731-742.
51. Nougairede A, Ninove L, Zandotti C. Point of care strategy for rapid diagnosis of novel A/H1N1 influenza virus. PLoS ONE 2010, 5:e9215.
52. Bergeron MG, Ke D, Ménard C. Rapid detection of Group B streptococci in pregnant women at delivery. N Engl J Med 2000, 343:175-179.
53. Tran NK, Wisner D, Albertson T. Quantitative point-of-care pathogen in septicemia. Point Care 2008, 7:107-110.
54. Dierkes C, Ehrenstein B, Siebig S. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009, 9:126.
55. Westh H, Lisby G, Breysse F. Mutliplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009, 15:544-551.
56. Lee HH, Dineva MA, Chua YL. Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing. J Infect Dis 2010, 201:S65-S71.
57. Jeong Y-J, Park K, Kim D-E. Isothermal DNA amplification in vitro: the helicase-dependent amplification system. Cell Mol Life Sci 2009, 66:3325-3336.
58. Mori Y, Notomi T. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J Infect Chemother 2009, 15:62-69.
59. Andresen D, von Nickish-Rosenegk M, Bier FF. Helicase-dependent amplification: use in OnChip amplification and potential for point-of-care diagnostics. Expert Rev Mol Diagn 2009, 9:645-650.
60. Fang X, Liu Y, Kong J, Jiang X. Loop-mediated isothermal amplification integrated on microfluidic chips for point-of-care quantitative detection of pathogens. Anal Chem 2010, 82:3002-3006.
61. Miller MB, Tang Y-W. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009, 22:611-633.
62. Situma C, Hashimoto M, Soper SA. Merging microfluidics with microarray-based bioassays. Biomol Eng 2006, 23:213-231.
63. Mark D, Haeberle S, Roth G. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. Chem Soc Rev 2010, 39:1153-1182.
64. Bergeron MG. Revolutionizing the practice of medicine through rapid (< 1h) DNA-based diagnostics. Clin Invest Med 2008, 31:E265-E271.
65. Brennan D, Justice J, Corbett B. Emerging optofluidic technologies for point-of-care genetic analysis systems: a review. Anal Bioanal Chem 2009, 395:621-636.
66. Kiechle FL, Holland CA. Point-of-care testing and molecular diagnostics: miniaturization required. Clin Lab Med 2009, 29:555-560.
67. Ligler FS. Perspective on optical biosensors and integrated sensor systems. Anal Chem 2009, 81:519-526.
68. Siegrist J, Peytavi R, Bergeron MG, Madou M. Microfluidics for IVD analysis: triumphs and hurdles of centrifugal platforms-Part 1: molecular fundamentals. IVD Technol 2009, 15:27-33.
69. Siegrist J, Peytavi R, Bergeron MG, Madou M. Microfluidics for IVD analysis: triumphs and hurdles of centrifugal platforms-Part 2: Centrifugal microfluidics. IVD Technol 2010, 16:41-47.
70. Ehrmeyer SS, Laessig RH. Regulatory compliance for point-of-care testing: 2009 United States perspective. Clin Lab Med 2009, 29:463-478.
71. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu Rev Biomed Eng 2008, 10:107-144.
72. Madou M, Zoval J, Jia G. Lab on a CD. Annu Rev Biomed Eng 2006, 8:601-628.
73. Chin CD, Linder V, Sia SK. Lab-on-a-chip devices for global health: past studies and future opportunities. Lab Chip 2007, 7:41-57.
74. Myers FB, Lee LP. Innovations in optical microfluidic technologies for point-of-care diagnostics. Lab Chip 2008, 8:2015-2031.
75. Weigl B, Domingo G, LaBarre P, Gerlach J. Towards non- and minimally instrumented, microfluidics-based diagnostic devices. Lab Chip 2008, 8:1999-2014.
76. Carrilho E, Martinez AW, Whitesides GM. Understanding wax printing: a simple micropatterning process for paper-based microfluidics. Anal Chem 2009, 81:7091-7095.
77. Qiu X, Thompson JA, Chen Z. Finger-actuated, self-contained immunoassay cassettes. Biomed Microdevices 2009, 11:1175-1186.
78. Nie Z, Nijhuis CA, Gong J. Electrochemical sensing in paper-based microfluidic device. Lab Chip 2010, 10:477-483.
79. Seng P, Drancourt M, Gouriet F. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009, 49:543-551.
80. Christner M, Rohde H, Wolters M. Rapid identification of bacteria from positive blood culture bottles using MALDI-TOF mass spectrometry fingerprinting. J Clin Microbiol 2010, 48:1584-1591.
81. Marinach-Patrice C, Fekkar A, Atanasova R. Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS ONE 2010, 5:e8862.
82. Sauer S, Kliem M. Mass spectrometry tools for the classification and identification of bacteria. Nat Rev Microbiol 2010, 8:74-82.
83. Petrosino JF, Highlander S, Luna RA. Metagenomic pyrosequencing and microbial identification. Clin Chem 2009, 55:856-866.
84. Tweardy DJ, Belmont JW. 'Personalizing' academic medicine: opportunities and challenges in implementing genomic profiling. Transl Res 2009, 154:288-294.
85. Pettersson E, Lundeberg J, Ahmadian A. Generations of sequencing technologies. Genomics 2009, 93:105-111.
86. Xu M, Fujita D, Hanagata N. Perspectives and challenges of emerging single-molecule DNA sequencing technologies. Small 2009, 5:2638-2649.
87. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet 2010, 11:31-46.
88. Calleja M, Nordström M, Álvarez M. Highly sensitive polymer-based cantilever-sensors for DNA detection. Ultramicroscopy 2005, 105:215-222.
89. Ymeti A, Greve J, Lambeck PV. Fast, ultrasensitive virus detection using a Young interferometer sensor. Nano Lett 2007, 7:394-397.
90. Álvarez M, Carrascosa LG, Zinoviev K. Biosensors based on cantilevers. Methods Mol Biol 2009, 504:51-71.
91. Piliarik M, Vaisocherová H, Homola J. Surface plasmon resonance biosensing. Methods Mol Biol 2009, 503:65-88.
92. Hiep HM, Saito M, Nakamura Y, Tamiya E. RNA aptamer-based optical nanostructured sensor for highly sensitive and label-free detection of antigen-antibody reactions. Anal Bioanal Chem 2010, 396:2575-2581.
93. Hauck TS, Giri S, Gao Y, Chan WCW. Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Adv Drug Deliv Rev 2010, 62:438-448.
94. Kaittanis C, Santra S, Perez JM. Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. Adv Drug Deliv Rev 2010, 62:408-423.
95. Lee WG, Kim Y-G, Chung BG. Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev 2010, 62:449-457.
96. Tallury P, Malhotra A, Byrne LM, Santra S. Nanobioimaging and sensing of infectious diseases. Adv Drug Deliv Rev 2010, 62:424-437.
97. Lewandrowski K. Point-of-care testing: an overview and a look to the future (circa 2009, United States). Clin Lab Med 2009, 29:421-432.
98. Brouqui P, Puro V, Fusco FM. Infection control in the management of highly pathogenic infectious diseases: consensus from the European Network of Infectious Disease. Lancet Infect Dis 2009, 9:301-311.
99. Usdin M, Guillerm M, Calmy A. Patient needs and point-of-care requirement for HIV load testing in resource-limited settings. J Infect Dis 2010, 201:S73-S77.
100. Cunningham R, Jenks P, Northwood J. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 2007, 65:24-28.
101. Medical device home use initiative http://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/HomeHealthandConsumer/HomeUseDevices/UCM209056.pdf, Washington, DC, Center for Devices and Radiological Health, Available at: (last accessed 22 April 2010)
102. Kearns AJ, O'Mathúna DP, Scott PA. Diagnostic self-testing: autonomous choices and relational responsibilities. Bioethics 2010, 24:199-207.